John Shern

32PUBLICATIONS
314CO-AUTHORS
Molecular targetsCellular nervous systemSolid tumoursGene and molecular therapyNeurology and neuromuscular diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|Jul 14, 2026
CDK8 Inhibition Releases the Muscle Differentiation Block in Fusion-driven Alveolar Rhabdomyosarcoma.

|May 28, 2026
Fusion-positive rhabdomyosarcoma oncofusions share a common interactome.

|Apr 22, 2026
NAPRT expression and epigenetic regulation in pediatric rhabdomyosarcoma as a potential biomarker for NAMPT inhibition.

|Mar 28, 2026
Biological Advances and Current Challenges for Pediatric Rhabdomyosarcoma.

Katie E Hebron, Patience Odeniyide, Yun Wei

|Jan 08, 2026
SARC031: A Phase II Trial of Selumetinib and Sirolimus for Patients with Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumors (MPNST).

AeRang Kim, Karla V Ballman, Pamela L Wolters

|Dec 04, 2025
Activity of Direct KRAS(G12C) Inhibitors in Preclinical Models of Pediatric Cancer.

Hannah E Price, Stacey Stauffer, Hyun Lee

Pageof 6

Frequent Collaborators

6 joint publications

R Taylor Sundby

6 joint publications

Marielle Yohe

6 joint publications

Brigitte Widemann

6 joint publications

Eva Dombi